Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Joaquim Bellmunt
Based on 77 articles published since 2009
(Why 77 articles?)
||||
Expertise Level
The expertise of Joaquim Bellmunt ranks in the Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2019
  • Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. · IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Harvard Medical School, Boston, MD, USA. Electronic address: · Pubmed 31030123
  • Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Vita Salute San Raffaele University and Department of Urology, IRCCS San Raffaele Hospital, Milano, Italy. · Fox Chase Cancer Center, Philadelphia, PA. · Heinrich-Heine-University, Medical faculty, Department of Urology, Düsseldorf, Germany. · University of Washington, Seattle, WA. · University of Athens, Athens, Greece. · University of Utah, Salt Lake City, UT. · Wayne State University/Karmanos Cancer Center, Detroit, MI. · Center Georges-François Leclerc, Dijon, France. · Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada. · Memorial Sloan-Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY. · Pubmed 30292628
2018
  • a Medical Oncology Department , Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar , Barcelona , Spain. · b Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center , Harvard Medical School , Boston , MA , USA. · Pubmed 29540084
  • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. Electronic address: · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Cancer Environment Research Unit, Léon-Bérard Cancer Center, Claude-Bernard-Lyon University, Lyon, France. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Duke University Medical Center, Durham, NC, USA. · Geriatric Department, CHU Henri Mondor, APHP, Créteil, France. · Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Urology Department, Saint Jean Languedoc Hospital, Toulouse, France. · Pubmed 28478043
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, Hamilton, ON. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea. · Genentech Inc, South San Francisco, CA. · Pubmed 29706503
  • David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA · Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada · Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea · Lawrence Fong, University of California, San Francisco, San Francisco · David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain · Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT · Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan · Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy · Winald Gerritsen, Radboud University Medical Center, Nijmegen · Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands · Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia · Stephane Culine, Hôpital Saint-Louis, Paris, France · Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ · and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29590008
  • Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, USA. · Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Harvard Medical School, Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Pubmed 30168126
  • Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Urology, University Hospital Frankfurt, Frankfurt, Germany. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. Electronic address: · Pubmed 30139659
  • Division of Urology, Department of Surgery, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Urology, Department of Surgery, McGill University Health Center, Montreal, QC, Canada. · Department of Surgical Sciences, Urology, University of Turin, Turin, Italy. · Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Institute of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany. · Academic Urology Unit, University of Sheffield, Sheffield, UK. · Division of Urology, Department of Surgery, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 30017405
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. · Clinical and Translational Science Institute, University of Rochester, Rochester, NY, 14642, USA. · Department of Biostatistics, The State University of New York at Buffalo, Buffalo, NY, 14214, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, 02215, USA. · Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China. · Department of Pathogen Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. · Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. · Pubmed 29926345
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Henry Ford Hospital, Vattikuti Institute of Urology, Center for Outcomes Research, Analytics and Evaluation, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29277584
  • a Department of Radiation Oncology , University Hospital of Besançon , Besançon , France. · b Department of Biostatistics , Georges François Leclerc Center, University of Burgundy , Dijon , France. · c Icahn School of Medicine at Mount Sinai , New York , NY , USA. · d Memorial Sloan Kettering Cancer Center , New York , NY , USA. · e Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA. · f Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London , London , UK. · g Medical Oncology Department , Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS , Meldola , Italy. · h Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , MA , USA. · i Guy's and St. Thomas' Hospital , London , UK. · j Heinrich-Heine-University , Düsseldorf , Germany. · k Fred Hutchinson Cancer Research Center , Seattle , WA , USA. · l City of Hope Comprehensive Cancer Center , Duarte , CA , USA. · m Department of Medical Oncology , Southampton General Hospital , Southampton , UK. · n Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA. · o Department of Medical Oncology , Georges François Leclerc Cancer Center, University of Burgundy , Dijon , France. · p Department of Radiation Oncology , Georges François Leclerc Cancer Center, University of Burgundy , Dijon , France. · Pubmed 28853615
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Fox Chase Cancer Center, Philadelphia, PA, USA. · City of Hope Comprehensive Cancer Center, Duarte, CA, USA. · UAB Comprehensive Cancer Center, Birmingham, AL, USA. · Dana Farber Cancer Institute, Boston, MA, USA. · University of Southampton, Southampton, UK. · University of Michigan, Ann Arbor, MI, USA. · Guy's and St. Thomas' Hospital, London, UK. · IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy. · Stanford University School of Medicine, Stanford, CA, USA. · University of Utah, Salt Lake City, UT, USA. · University of Athens, Athens, Greece. · Rabin Medical Center, Petach Tikva, Israel. · Medical University of South Carolina, Charleston, SC, USA. · Centre Georges-François Leclerc, Dijon, France. · San Camillo Forlanini Hospital, Rome, Italy. · University of Washington, Seattle, WA, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Liverpool, Liverpool, UK. · Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, CO, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA. · Hopital Foch, Suresnes, France. · Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Princess Margaret Hospital, University Health Network, Toronto, Canada. · Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA. · Pubmed 28753879
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Pubmed 29259186
  • Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada. · Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · PSMAR-IMIM Lab, Bladder Cancer Center, Department of Medicine, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. · Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Bioinformatics and Systems Biology Laboratory, Federal University of Paraná Polytechnic Center, Curitiba, PR CEP 80.060-000, Brazil. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biostatistics and Computational Biology Laboratory, Department of Statistics, University of Campinas, São Paulo, 13.083-859, Brazil. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Biospecimen Core Resource, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pathology and Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21218, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. Electronic address: · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: · Pubmed 28988769
  • Dana-Farber Cancer Institute and IMIM-PSMAR Medical Research Institute, Boston, MA 02215, USA. Electronic address: · Pubmed 28916369
  • University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. · Dana-Farber Cancer Institute, Brookline, MA, 02446, USA. · Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA. · University of Minnesota, Minneapolis, MN, 55455, USA. · BCG Oncology, Phoenix, AZ, 85032, USA. · Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA. · The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. · University of North Carolina, Chapel Hill, NC, 27599, USA. · University of Iowa, Iowa City, IA, 52242, USA. · University of Chicago, Chicago, IL, 60637, USA. · Yale Cancer Center, New Haven, CT, 06520, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Stanford University, Stanford, CA, 94305, USA. · University of Alabama, Birmingham, AL, 35294, USA. · University of Kansas Cancer Center, Kansas City, KS, 66160, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 28807024
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Biostatistics, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Urology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28487100
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University of Alabama Comprehensive Cancer Center, Birmingham, AL. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Pubmed 28478885
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Avenue South, Birmingham, Alabama 35294, USA. · Dana Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Pubmed 27071455
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27310333
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital · and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Precision Oncology Laboratory, Infanta Sofia University Hospital, Madrid, Spain. · Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain. · Clinical Research Unit, Jimenez Diaz Foundation, Madrid, Spain. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, USA. · Pubmed 27111282
  • University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: · McMaster University, Ontario, Canada. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 26415779
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Director, Bladder Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA. Electronic address: · Pubmed 25836942
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 45, Francis street, Boston, MA 02115, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 26612221
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester · Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School · Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School · Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California. · Department of Urology, Guy's and St. Thomas' Hospital, London, United Kingdom. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Medical Oncology, Barts Cancer Institute, London, United Kingdom. · Division of Biostatistics, Department of Preventative Medicine, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France. · Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · Department of Hematology and Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan. · Department of Medical Oncology, Samuel and Barbara Sternberg Cancer Research Foundation, Rome, Italy. · Department of Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Medical Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy. · Department of Oncology, Hospital Foch, Suresnes, France. · Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25872978
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
  • Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Statistics, McMaster University, Hamilton, Ontario, Canada. · Department of Medicine, University Federico II, Naples, Italy. · Department of Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, City of Hope Cancer Center, Duarte, CA. · Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · Department of Medicine, Wayne State University Cancer Center, Detroit, MI. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medicine, University of Arizona, Tucson, AZ. · Department of Medicine, Dana Farber Cancer Institute, Boston, MA. · Department of Medicine, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 25450035
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Barts Cancer Institute, Queen Mary University of London, Barts Experimental Cancer Medicine Centre, London EC1M 6BQ, UK. · Yale Cancer Center, 333 Cedar Street, WWW211, New Haven, Connecticut 06520, USA. · Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, USA. · Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif, France. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital. Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Sarah Cannon Research Institute, 3322 West End Avenue, Suite 900, Nashville, Tennessee 37203, USA. · University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Pubmed 25428503
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital · Christopher Tretter, Lahey Clinic, Burlington · Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA · Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA · and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24568895
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Urology, Stanford University Medical Center, Stanford, CA, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24491306
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
2015
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 24674655
2014
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
Probable:    Hospital del Mar      
2019
  • Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. · IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Harvard Medical School, Boston, MD, USA. Electronic address: · Pubmed 31030123
  • Department of Urology, Tan Tock Seng Hospital, Singapore, Singapore. · Department of Urology, University of Tübingen, Tübingen, Germany. · Department of Urology and Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA. · Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Solna, Sweden. · Orsi Academy, Melle, Belgium. · USC Institute of Urology, University of Southern California, Los Angeles, CA, USA. · Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Urology, University Hospital of Cologne, Cologne, Germany. · Department of Urology, University of Rochester Medical Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · Department of Radiation Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. · Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · Genitourinary Division, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, University of Lille Nord de France, Lille, France. · Genitourinary Division, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · PSMAR-IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain. · Department of Urology, University of Tübingen, Tübingen, Germany. · Pubmed 30684034
2018
  • a Medical Oncology Department , Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar , Barcelona , Spain. · b Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center , Harvard Medical School , Boston , MA , USA. · Pubmed 29540084
  • Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, USA. · Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Harvard Medical School, Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Pubmed 30168126
2017
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • University of Washington, Seattle, Washington. · Icahn School of Medicine at Mount Sinai, New York, New York. · University of Southampton, Southampton, England. · National and Kapodistrian University of Athens, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Hospital del Mar, Barcelona, Spain. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Georges François Leclerc Center, Dijon, France. · Université de Bourgogne, Dijon, France. · Barts and the London School of Medicine, London, England. · City of Hope, Duarte, California. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Michigan, Ann Arbor, Michigan. · University of Utah, Salt Lake City, Utah. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Karmanos Cancer Institute, Detroit, Michigan. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28000388
2016
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
2015
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester · Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School · Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School · Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2011
2010
  • Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain. · Pubmed 20231682
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2011
  • Medical Oncology Service, University Hospital del Mar, Barcelona, Spain. · Pubmed 21360040
Probable:    Massachusetts Institute of Technology      
2017
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Pubmed 29259186
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 77 total) written by Joaquim Bellmunt about Urinary Bladder Neoplasms:

  • Management of metastatic bladder cancer. 2019
  • SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. 2019
  • Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. 2019
  • Avelumab for the treatment of urothelial cancer. 2018
  • Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. 2018
  • Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy. 2018
  • Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer. 2018
  • The Cancer Genome Atlas Project in Bladder Cancer. 2018
  • Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis. 2018
  • Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations. 2018
Show List of Full Article Records
Google Searches

Learn more about Joaquim Bellmunt using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Hospital del Mar
Massachusetts Institute of Technology
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2019
  • Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. · IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Harvard Medical School, Boston, MD, USA. Electronic address: · Pubmed 31030123
  • Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Vita Salute San Raffaele University and Department of Urology, IRCCS San Raffaele Hospital, Milano, Italy. · Fox Chase Cancer Center, Philadelphia, PA. · Heinrich-Heine-University, Medical faculty, Department of Urology, Düsseldorf, Germany. · University of Washington, Seattle, WA. · University of Athens, Athens, Greece. · University of Utah, Salt Lake City, UT. · Wayne State University/Karmanos Cancer Center, Detroit, MI. · Center Georges-François Leclerc, Dijon, France. · Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada. · Memorial Sloan-Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY. · Pubmed 30292628
2018
  • a Medical Oncology Department , Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar , Barcelona , Spain. · b Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center , Harvard Medical School , Boston , MA , USA. · Pubmed 29540084
  • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. Electronic address: · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Cancer Environment Research Unit, Léon-Bérard Cancer Center, Claude-Bernard-Lyon University, Lyon, France. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Duke University Medical Center, Durham, NC, USA. · Geriatric Department, CHU Henri Mondor, APHP, Créteil, France. · Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Urology Department, Saint Jean Languedoc Hospital, Toulouse, France. · Pubmed 28478043
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, Hamilton, ON. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea. · Genentech Inc, South San Francisco, CA. · Pubmed 29706503
  • David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA · Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada · Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea · Lawrence Fong, University of California, San Francisco, San Francisco · David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain · Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT · Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan · Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy · Winald Gerritsen, Radboud University Medical Center, Nijmegen · Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands · Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia · Stephane Culine, Hôpital Saint-Louis, Paris, France · Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ · and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29590008
  • Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, USA. · Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Harvard Medical School, Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Pubmed 30168126
  • Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Urology, University Hospital Frankfurt, Frankfurt, Germany. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Vattikuti Urology Institute, Vattikuti Urology Institute (VUI) Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI. Electronic address: · Pubmed 30139659
  • Division of Urology, Department of Surgery, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Urology, Department of Surgery, McGill University Health Center, Montreal, QC, Canada. · Department of Surgical Sciences, Urology, University of Turin, Turin, Italy. · Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Institute of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany. · Academic Urology Unit, University of Sheffield, Sheffield, UK. · Division of Urology, Department of Surgery, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 30017405
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. · Clinical and Translational Science Institute, University of Rochester, Rochester, NY, 14642, USA. · Department of Biostatistics, The State University of New York at Buffalo, Buffalo, NY, 14214, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, 02215, USA. · Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China. · Department of Pathogen Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. · Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. · Pubmed 29926345
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Henry Ford Hospital, Vattikuti Institute of Urology, Center for Outcomes Research, Analytics and Evaluation, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29277584
  • a Department of Radiation Oncology , University Hospital of Besançon , Besançon , France. · b Department of Biostatistics , Georges François Leclerc Center, University of Burgundy , Dijon , France. · c Icahn School of Medicine at Mount Sinai , New York , NY , USA. · d Memorial Sloan Kettering Cancer Center , New York , NY , USA. · e Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA. · f Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London , London , UK. · g Medical Oncology Department , Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS , Meldola , Italy. · h Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , MA , USA. · i Guy's and St. Thomas' Hospital , London , UK. · j Heinrich-Heine-University , Düsseldorf , Germany. · k Fred Hutchinson Cancer Research Center , Seattle , WA , USA. · l City of Hope Comprehensive Cancer Center , Duarte , CA , USA. · m Department of Medical Oncology , Southampton General Hospital , Southampton , UK. · n Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA. · o Department of Medical Oncology , Georges François Leclerc Cancer Center, University of Burgundy , Dijon , France. · p Department of Radiation Oncology , Georges François Leclerc Cancer Center, University of Burgundy , Dijon , France. · Pubmed 28853615
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Fox Chase Cancer Center, Philadelphia, PA, USA. · City of Hope Comprehensive Cancer Center, Duarte, CA, USA. · UAB Comprehensive Cancer Center, Birmingham, AL, USA. · Dana Farber Cancer Institute, Boston, MA, USA. · University of Southampton, Southampton, UK. · University of Michigan, Ann Arbor, MI, USA. · Guy's and St. Thomas' Hospital, London, UK. · IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy. · Stanford University School of Medicine, Stanford, CA, USA. · University of Utah, Salt Lake City, UT, USA. · University of Athens, Athens, Greece. · Rabin Medical Center, Petach Tikva, Israel. · Medical University of South Carolina, Charleston, SC, USA. · Centre Georges-François Leclerc, Dijon, France. · San Camillo Forlanini Hospital, Rome, Italy. · University of Washington, Seattle, WA, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Liverpool, Liverpool, UK. · Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, CO, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA. · Hopital Foch, Suresnes, France. · Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Princess Margaret Hospital, University Health Network, Toronto, Canada. · Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA. · Pubmed 28753879
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Pubmed 29259186
  • Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada. · Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · PSMAR-IMIM Lab, Bladder Cancer Center, Department of Medicine, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. · Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Bioinformatics and Systems Biology Laboratory, Federal University of Paraná Polytechnic Center, Curitiba, PR CEP 80.060-000, Brazil. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biostatistics and Computational Biology Laboratory, Department of Statistics, University of Campinas, São Paulo, 13.083-859, Brazil. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Biospecimen Core Resource, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pathology and Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21218, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. Electronic address: · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: · Pubmed 28988769
  • Dana-Farber Cancer Institute and IMIM-PSMAR Medical Research Institute, Boston, MA 02215, USA. Electronic address: · Pubmed 28916369
  • University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. · Dana-Farber Cancer Institute, Brookline, MA, 02446, USA. · Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA. · University of Minnesota, Minneapolis, MN, 55455, USA. · BCG Oncology, Phoenix, AZ, 85032, USA. · Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA. · The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. · University of North Carolina, Chapel Hill, NC, 27599, USA. · University of Iowa, Iowa City, IA, 52242, USA. · University of Chicago, Chicago, IL, 60637, USA. · Yale Cancer Center, New Haven, CT, 06520, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Stanford University, Stanford, CA, 94305, USA. · University of Alabama, Birmingham, AL, 35294, USA. · University of Kansas Cancer Center, Kansas City, KS, 66160, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 28807024
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Biostatistics, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Urology, Vall d'Hebron Hospital, Barcelona, Spain. · Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. · Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28487100
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University of Alabama Comprehensive Cancer Center, Birmingham, AL. · Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Pubmed 28478885
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Avenue South, Birmingham, Alabama 35294, USA. · Dana Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Pubmed 27071455
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27310333
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital · and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Precision Oncology Laboratory, Infanta Sofia University Hospital, Madrid, Spain. · Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain. · Clinical Research Unit, Jimenez Diaz Foundation, Madrid, Spain. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, USA. · Pubmed 27111282
  • University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: · McMaster University, Ontario, Canada. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 26415779
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Director, Bladder Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA. Electronic address: · Pubmed 25836942
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 45, Francis street, Boston, MA 02115, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 26612221
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester · Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School · Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School · Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California. · Department of Urology, Guy's and St. Thomas' Hospital, London, United Kingdom. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Medical Oncology, Barts Cancer Institute, London, United Kingdom. · Division of Biostatistics, Department of Preventative Medicine, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France. · Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · Department of Hematology and Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan. · Department of Medical Oncology, Samuel and Barbara Sternberg Cancer Research Foundation, Rome, Italy. · Department of Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Medical Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy. · Department of Oncology, Hospital Foch, Suresnes, France. · Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25872978
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
  • Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Statistics, McMaster University, Hamilton, Ontario, Canada. · Department of Medicine, University Federico II, Naples, Italy. · Department of Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, City of Hope Cancer Center, Duarte, CA. · Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · Department of Medicine, Wayne State University Cancer Center, Detroit, MI. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medicine, University of Arizona, Tucson, AZ. · Department of Medicine, Dana Farber Cancer Institute, Boston, MA. · Department of Medicine, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 25450035
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Barts Cancer Institute, Queen Mary University of London, Barts Experimental Cancer Medicine Centre, London EC1M 6BQ, UK. · Yale Cancer Center, 333 Cedar Street, WWW211, New Haven, Connecticut 06520, USA. · Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, USA. · Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif, France. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital. Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Sarah Cannon Research Institute, 3322 West End Avenue, Suite 900, Nashville, Tennessee 37203, USA. · University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Pubmed 25428503
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital · Christopher Tretter, Lahey Clinic, Burlington · Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA · Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA · and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24568895
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Urology, Stanford University Medical Center, Stanford, CA, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24491306
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
2015
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 24674655
2014
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
Hospital del Mar
2019
  • Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. · IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Harvard Medical School, Boston, MD, USA. Electronic address: · Pubmed 31030123
  • Department of Urology, Tan Tock Seng Hospital, Singapore, Singapore. · Department of Urology, University of Tübingen, Tübingen, Germany. · Department of Urology and Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA. · Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Solna, Sweden. · Orsi Academy, Melle, Belgium. · USC Institute of Urology, University of Southern California, Los Angeles, CA, USA. · Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Urology, University Hospital of Cologne, Cologne, Germany. · Department of Urology, University of Rochester Medical Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · Department of Radiation Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. · Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · Genitourinary Division, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, University of Lille Nord de France, Lille, France. · Genitourinary Division, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · PSMAR-IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain. · Department of Urology, University of Tübingen, Tübingen, Germany. · Pubmed 30684034
2018
  • a Medical Oncology Department , Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar , Barcelona , Spain. · b Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center , Harvard Medical School , Boston , MA , USA. · Pubmed 29540084
  • Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, USA. · Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain. · Harvard Medical School, Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Pubmed 30168126
2017
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • University of Washington, Seattle, Washington. · Icahn School of Medicine at Mount Sinai, New York, New York. · University of Southampton, Southampton, England. · National and Kapodistrian University of Athens, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Hospital del Mar, Barcelona, Spain. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Georges François Leclerc Center, Dijon, France. · Université de Bourgogne, Dijon, France. · Barts and the London School of Medicine, London, England. · City of Hope, Duarte, California. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Michigan, Ann Arbor, Michigan. · University of Utah, Salt Lake City, Utah. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Karmanos Cancer Institute, Detroit, Michigan. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28000388
2016
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
2015
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester · Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School · Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School · Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2011
2010
  • Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain. · Pubmed 20231682
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2011
  • Medical Oncology Service, University Hospital del Mar, Barcelona, Spain. · Pubmed 21360040
Massachusetts Institute of Technology
2017
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Pubmed 29259186
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
Harvard University Cambridge
2017
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA. · Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. · Pubmed 29259186
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
Miscellaneous institutions in Barcelona
2015
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
Universitat Autonoma de Barcelona
2012
  • Medical Oncology Service, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 23040256
2012
  • Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Pubmed 22595043
12 Other Locations Show
Yearly article counts 311129121376310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.